Tuberculosis News and Research

Latest Tuberculosis News and Research

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, and other innovative technologies, today announced it has received an offer for funding from a biotech-oriented investment group called BIOTECH Development Partners, LLC.

9 Mar 2011

Belly laugh best for venous leg ulcers

Forget technology. The best prescription for patients with venous leg ulcers is good quality nursing care - and the occasional belly laugh!

9 Mar 2011

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

A recent trial of rituximab in combination with a tumor necrosis factor inhibitor and methotrexate in patients with active rheumatoid arthritis found the safety profile to be consistent with other RA trials with TNF inhibitors.

8 Mar 2011

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

Anacor Pharmaceuticals (NASDAQ:ANAC) and the Institute for OneWorld Health (iOWH) today announced the establishment of a joint research agreement to discover antibacterial compounds for treating shigellosis.

8 Mar 2011

New discovery holds promise for TB treatment

New findings on how tuberculosis bacteria develop multi-drug tolerance point to ways TB infections might be cured more quickly.

4 Mar 2011

Protesters call on Indian government to reject free trade agreement with EU

Thousands of HIV-positive people from India and across Asia marched in New Delhi on Wednesday to protest the proposed free trade agreement between the European Union and India, "which has provisions that would restrict access to affordable medicines," the Times of India reports.

4 Mar 2011

Ekomed to collaborate with Immune Network and Immunitor for further research of Immunoxel/Dzherelo

Immune Network Ltd. advises that Ukrainian company Ekomed LLC has agreed to collaborate with Immune Network and Immunitor for further clinical research of a tableted form of Ekomed's well-known immunomodulator herbal product Immunoxel/Dzherelo.

4 Mar 2011

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

The American Thoracic Society has released a new report detailing recent global changes in the management of human immunodeficiency virus-associated pulmonary disease.

4 Mar 2011

Britain to cut foreign aid for 16 countries, focus more on family planning, safe water, maternal mortality

British Secretary of State for International Development Andrew Mitchell on Tuesday announced major changes to the nation's international aid program based on a nine-month review of the agency's policies, Reuters reports.

3 Mar 2011

Inter Press Service explores how Kenya's Anti-Counterfeit Act, possible EU-India free trade agreement could scale back access to affordable medications

Inter Press Service examines how legislation in Kenya targeting counterfeit medications and a possible EU-India Free Trade Agreement could scale back access to affordable and safe generic medications widely used in developing countries.

2 Mar 2011

New insight into HIV/AIDS

A paper published in the March 2011 print edition of the Journal of Clinical Investigation offers new insight into what prompts immunity to AIDS in sooty mangabeys, a natural host African monkey species.

2 Mar 2011

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.

2 Mar 2011

Intercell reports EUR 255.2m net loss for full year 2010

Today Intercell AG announced its financial results for Q4 and the preliminary results for the full financial year 2010 and presented an update on the Company's development programs.

1 Mar 2011

Immunitor to present latest results from imm01 trial in tuberculosis patients at African conference

Immune Network Ltd. advises that Immunitor will present latest results from its imm01 clinical trial in tuberculosis patients in Abuja, Nigeria at the 18th Union TB and Lung Diseases Conference of the African Region, 2nd to 5th March, 2011.

28 Feb 2011

MEPs, OETC visit new TB vaccine trial site to express support for candidate development

Emergent BioSolutions Inc. announced that a joint delegation of Members of the European Parliament and representatives from the Oxford-Emergent Tuberculosis Consortium today visited the trial site where MVA85A, the world's most clinically advanced tuberculosis vaccine candidate in development, is being studied in a Phase IIb infant efficacy clinical trial.

28 Feb 2011

Opinions: Foreign aid lessons from Britain; food security; Global Fund investigation; U.S. food aid cuts; Africa needs trade

"Before Republican budget hawks wield their knife, ... they should take a lesson from their conservative cousins in the United Kingdom: When belt-tightening gets serious, foreign aid should be improved, not gutted," according to an opinion piece in the New Republic written by Thomas Carothers, vice president for studies at the Carnegie Endowment for International Peace.

24 Feb 2011

Daily report global health conversations: Health sector corruption

Recent media reports have drawn attention to an internal audit that revealed several countries' misuse of Global Fund to Fight AIDS, Tuberculosis and Malaria grant money, totaling $34 million.

24 Feb 2011

New diagnostic tool to detect patients with active TB disease

Tuberculosis remains one of the most pressing public health priorities for the 21st century, with over one third of the world population infected. Active TB disease is a major issue both for the patients who require specific treatment and at a population level, since these patients are contagious.

21 Feb 2011

New tuberculosis vaccine provides better protection

Nele Festjens and Nico Callewaert of VIB and Ghent University have improved the efficacy of the vaccine for tuberculosis. The new vaccine affords - as already proven in mice - better protection against the disease. The development of a new tuberculosis vaccine is a priority in the fight against the disease which claims the lives of 1.7 million people each year. The current vaccine provides only partial protection.

19 Feb 2011

Media examines foreign aid stakeholders' reactions to FY11, FY12 budgets

In the wake of President Barack Obama's fiscal year 2012 budget proposal and the negotiation of the fiscal year 2011 budget bill in the House of Representatives, news outlets looked at stakeholders' responses to the measures and analyzed different pieces of the bills.

18 Feb 2011

Tuberculosis News and Research

Latest Tuberculosis News and Research

BMGP receives BIOTECH Development Partners offer to commercialize optical biosensor

Belly laugh best for venous leg ulcers

Recent rituximab trial with TNF inhibitors reports no new safety risks in patients with RA

Anacor and iOWH establish research agreement to identify new drugs for shigellosis

New discovery holds promise for TB treatment

Protesters call on Indian government to reject free trade agreement with EU

Ekomed to collaborate with Immune Network and Immunitor for further research of Immunoxel/Dzherelo

ATS releases new report detailing emerging trends in HIV-linked pulmonary disease management

Britain to cut foreign aid for 16 countries, focus more on family planning, safe water, maternal mortality

Inter Press Service explores how Kenya's Anti-Counterfeit Act, possible EU-India free trade agreement could scale back access to affordable medications

New insight into HIV/AIDS

OneWorld Health receives FDA clearance for iOWH032 phase 1 trials to treat secretory diarrhea

Intercell reports EUR 255.2m net loss for full year 2010

Immunitor to present latest results from imm01 trial in tuberculosis patients at African conference

MEPs, OETC visit new TB vaccine trial site to express support for candidate development

Opinions: Foreign aid lessons from Britain; food security; Global Fund investigation; U.S. food aid cuts; Africa needs trade

Daily report global health conversations: Health sector corruption

New diagnostic tool to detect patients with active TB disease

New tuberculosis vaccine provides better protection

Media examines foreign aid stakeholders' reactions to FY11, FY12 budgets

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in